欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号ES/H/0706/003
药品名称Ceftazidime 2g powder for solution for injection
活性成分
    • ceftazidime pentahydrate 2.0 g
剂型Powder for solution for injection or infusion
上市许可持有人Head of Regulatory Affairs QILU PHARMA SPAIN SL PASEO DE LA CASTELLANA 40 PLANTA 8 MADRID E-28046 SPAIN
参考成员国 - 产品名称Spain (ES)
互认成员国 - 产品名称
    • Hungary (HU)
      CEFTAZIDIME QILU 2 g por oldatos injekcióhoz vagy infúzióhoz
    • United Kingdom (Northern Ireland) (XI)
    • Germany (DE)
      Ceftazidim Qilu 2,0 g Pulver zur Herstellung einer Injektions- bzw. Infusionslösung
    • France (FR)
    • Italy (IT)
许可日期2018/03/22
最近更新日期2023/05/22
药物ATC编码
    • J01DD02 ceftazidime
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:[not specified]
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase